Long-term tolerability and efficacy of the combination of amlodipine/valsartan in hypertensive patients: a 54-week, open-label extension study.

@article{Philipp2009LongtermTA,
  title={Long-term tolerability and efficacy of the combination of amlodipine/valsartan in hypertensive patients: a 54-week, open-label extension study.},
  author={Thomas Philipp and Robert D. Glazer and Yanxing Zhao and Rainer Pospiech},
  journal={Current medical research and opinion},
  year={2009},
  volume={25 1},
  pages={187-93}
}
OBJECTIVE To evaluate the long-term tolerability and efficacy of the amlodipine/valsartan 5/320 mg once daily (o.d.) combination in hypertensive patients. METHODS This was a 54-week, multicenter, open-label extension study in patients with mild-to-moderate essential hypertension selected after successfully completing a core study during which they received either placebo, amlodipine, valsartan or combination therapy. Eligible patients (mean sitting diastolic blood pressure [MSDBP] < or = 95… CONTINUE READING